AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2025
Aug 28, 2025
29745_dirs_2025-08-28_e6cbc569-5cf4-4399-9ebe-b5f8a36c360b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-08-27
Reporting Person: Custer Kenneth L. (EVP & President, Card Met Hlth)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-27 | Phantom Stock | $ | I | 612.937 | Acquired | Common Stock (612.937) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9346.902 | Direct |
Footnotes
F1: Each share of phantom stock represents the right to receive the cash value of one share of Eli Lilly and Company common stock.
F2: Reflects reallocation of funds within the reporting person's deferred compensation account.
F3: Shares of phantom stock are payable in cash following termination of the reporting person's employment with Eli Lilly and Company.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29